S, F., L, D., RR, S., AB, S., PH, L., LM, R., . . . AL, A. (2024). Can Genomic Testing Help Refine Choosing Wisely the Omission of Axillary Staging in cN0 Breast Cancer? The Journal of surgical research, 301, 345. https://doi.org/10.1016/j.jss.2024.06.025
Chicago Style (17th ed.) CitationS, Fang, Drapalik L, Shenk RR, Simpson AB, Li PH, Rock LM, Miller ME, and Amin AL. "Can Genomic Testing Help Refine Choosing Wisely the Omission of Axillary Staging in CN0 Breast Cancer?" The Journal of Surgical Research 301 (2024): 345. https://doi.org/10.1016/j.jss.2024.06.025.
MLA (9th ed.) CitationS, Fang, et al. "Can Genomic Testing Help Refine Choosing Wisely the Omission of Axillary Staging in CN0 Breast Cancer?" The Journal of Surgical Research, vol. 301, 2024, p. 345, https://doi.org/10.1016/j.jss.2024.06.025.